August 5th 2025
Patients with extramedullary disease had inferior progression-free survival.
HRQOL Decreased During and Immediately After CAR T-Cell Therapy for DLBCL
November 16th 2021Prior to chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma (DLBCL), patients experienced a decrease in health-related quality of life (HRQOL), which was further impaired during and immediately after CAR T therapy.
Read More
Teprotumumab Benefits Patients With Mild Inflammation and Real-world Adherence Remains High
November 15th 2021Posters presented at the American Academy of Ophthalmology 2021 annual meeting showed that even patients with mild inflammation with their thyroid eye disease benefitted from teprotumumab and that real-world adherence was consistent with the pivotal clinical trials.
Read More
Teprotumumab, Enhanced Monofocal IOLs Among Hot Topics at AAO 2021
November 15th 2021Among many presentations during a hot topics session at the American Academy of Ophthalmology 2021 annual meeting, speakers discussed the first FDA approved therapy for thyroid eye disease and the latest in enhanced monofocal intraocular lenses (IOLs).
Read More
Ophthalmology at Crossroads for Information Technology, AI
November 14th 2021The field of ophthalmology had already been moving toward telehealth and artificial intelligence (AI) before the COVID-19 pandemic, but these changes are being accelerated now, making it crucial for ophthalmologists to learn to adapt.
Read More
Pathologists Discuss Actionable Mutations and Testing in Metastatic Breast Cancer
November 14th 2021Genetic profiling in recurrent and advanced breast cancer can yield actionable, smoking-gun biomarkers, Stanford Cancer Institute pathologists explained at the National Comprehensive Cancer Network 2021 Virtual Congress: Biomarkers in Solid Tumors.
Read More
Posters at AAO 2021 Analyze ED Utilization for Nonemergency Ophthalmic Conditions
November 13th 2021Emergency department utilization for nonemergent ophthalmic conditions is on the rise in the United States, but presentation types vary significantly based on patient demographics, according to 2 posters presented at the American Academy of Ophthalmology (AAO) 2021 meeting.
Read More
Dr William Katowitz Discusses Pediatric Ophthalmic Surgical Decisions
November 13th 2021Surgical decisions with children who have ophthalmic conditions need buy in from parents, but also the children as they get older, said William Katowitz, MD, attending surgeon in the Division of Ophthalmology at Children's Hospital of Philadelphia.
Watch
Access to Optimal Care Has Stymied Visual Acuity Gains in AMD With Anti-VEGF Treatment
November 13th 2021The real-world visual acuity gains in age-related macular degeneration (AMD) after treatment have been inferior to those seen in clinical trials, explained a speaker during the American Academy of Ophthalmology 2021 meeting.
Read More
Survey of Australian Oncologists Finds Room for Increasing Their Confidence With CGP
November 12th 2021A recent survey of oncologists in Australia showed that while most are integrating comprehensive genomic profiling (CGP) into their practice, they lack a high level of confidence to communicate findings and to adjust patient treatment accordingly.
Read More
Recommendations, Insights on Use of Comprehensive Genomic Profiling in Oncology
November 12th 2021A discussion at the National Comprehensive Cancer Network 2021 Virtual Congress: Biomarkers in Solid Tumors addressed the advantages and considerations for broad and targeted genomic profiling in oncology.
Read More
Prior Biologic Use, Body Weight May Impact Guselkumab Efficacy in Psoriasis
November 12th 2021Real-world patients with moderate-to-severe psoriasis were shown to exhibit impaired efficacy with guselkumab treatment if they had history of prior biologic use, particularly anti-interleukin (IL)-17 exposure, with heavier patients linked with delayed onset of therapeutic response.
Read More
Dr Robert Fante Outlines the Importance of Teprotumumab, the First Approved Therapy for TED
November 12th 2021Unlike other options in the past, teprotumumab actually addresses bulging eye and double vision associated with thyroid eye disease (TED), which patients primarily care about, explained Robert G. Fante, MD, FACS, president of the American Society of Ophthalmic Plastic & Reconstructive Surgery and facial plastic surgeon and cosmetic surgeon, Fante Eye & Face Centre in Denver, Colorado.
Watch
Dr William Katowitz: Ptosis Surgery Is Usually Elective and There Are Alternatives
November 12th 2021Whether or not a child’s vision is impacted by ptosis, there are usually alternatives to surgery, which is elective, said William Katowitz, MD, attending surgeon in the Division of Ophthalmology at Children's Hospital of Philadelphia.
Watch
A National Perspective of the Opportunities, Challenges Facing Health Care Cost and Sustainability
November 11th 2021Michael E. Chernew, PhD, co-editor-in-chief of The American Journal of Managed Care®, discussed cost and sustainability issues specific to commercial insurance, Medicare, and Medicaid at the National Alliance 2021 Annual Forum held in a hybrid format in Washington, DC.
Read More
ASOPRS Fall Symposium Will Feature Innovations, Diversity, and Diet Presentations
November 9th 2021The American Society of Ophthalmic Plastic & Reconstructive Surgery 2021 Fall Scientific Symposium will feature presentations on oculofacial surgery innovations, social justice and diversity, and more.
Read More
Antidepressant Use Linked With Impaired REM Sleep, Quality of Life
November 8th 2021Findings of an abstract presented at CHEST 2021 indicated that antidepressant use was associated with increased REM sleep latency and a complete lack of REM sleep, which may contribute to the poorer quality-of-life scores observed in these patients.
Read More
Dr Shoaib Ugradar Explains Award-Winning Research on Floppy Eyelid Syndrome
November 8th 2021At the American Society of Ophthalmic Plastic & Reconstructive Surgery (ASOPRS) 2021 Fall Scientific Symposium, Shoaib Ugradar, MD, UCLA Stein Eye Center Santa Monica, will receive an award for his work on floppy eyelid syndrome and using collagen cross-linking to stiffen the eyelid and help patients.
Watch
The United States lifts travel restrictions for numerous countries, requiring proof of vaccination and in some cases negative COVID-19 tests; discrimination of any kind was associated with greater risk of mental health problems in young people; a controversial Alzheimer disease drug faces several uptake issues.
Read More
Dr Richard Wasserman on Changing Attitudes Toward Food Allergy OIT
November 8th 2021Richard Wasserman, MD, PhD, an allergist and immunologist with Allergy Partners of North Texas, an early adopter of food allergy oral immunotherapy (OIT), discusses how attitudes have changed around the practice.
Watch
In AD Biologics Debate, Therapy Choice Is Just Half of the Battle
November 5th 2021With new and expected future options for treating atopic dermatitis (AD), including an injectable biologic and an oral small molecule inhibitor, which is preferred and which makes the most sense for patients?
Read More
Dr Ruchi Gupta on Getting Peanut Introduction Feeding Guidelines Into Wider Practice
November 5th 2021In 2017, guidelines about when to feed peanuts to infants changed to recommend early feeding by 4 to 6 months of age depending on 3 risk levels, but these allergy prevention strategies are still not widespread, according to Ruchi Gupta, MD, MPH, professor of pediatrics and medicine, Northwestern Feinberg School of Medicine, who discussed the topic at the 2021 ACAAI Annual Scientific Meeting.
Watch
Dr Daniel Greer Discusses At-Risk Populations, Comorbidities of Chronic Insomnia
November 5th 2021Daniel Greer, PharmD, BCPP, clinical assistant professor, Rutgers Ernest Mario School of Pharmacy, speaks on at-risk populations of chronic insomnia, and the reciprocal relationship between the condition and other comorbidities.
Watch